High burden and low awareness of toxoplasmosis in the United States

References

• Furtado JM, Smith JR, Belfort R Jr, et al. Toxoplasmosis: a global threat. J Glob Infect Dis. 2011;3:281–284.
   PubMedGoogle Scholar
• Jones JL, Parise ME, Fiore AE. Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg. 2014;90:794–799.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control [Cited 2018 Sep 10]. Avialable from: https://www.cdc.gov/parasites/toxoplasmosis/.
   Google Scholar
• Montoya JG, Boothroyd JC, Kovacs JA. Toxoplasma gondii. 2015;280:3122-3153. In: Gerald M, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s principles and preactice of infectious diseases. 7th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2010.
   Google Scholar
• Jones JL, Kruszon-Moran D, Sanders-Lewis K, et al. Toxoplasma gondii infection in the United States, 1999–2004, decline from the prior decade. Am J Trop Med Hyg. 2007;77:405–410.
   PubMed Web of Science ®Google Scholar
• Jones JL, Kruszon-Moran D, Rivera H, et al. Toxoplasma gondii seroprevalence in the United States 2009–2010 and comparison with the past two decades. Am J Trop Med Hyg. 2014;90:1135–1139.
   PubMed Web of Science ®Google Scholar
• Jones JL, Kruszon-Moran D, Elder S, et al. Toxoplasma gondii Infection in the United States, 2011-2014. Am J Trop Med Hyg. 2018;98:551–557.
   PubMed Web of Science ®Google Scholar
• Ya M, Js R, Committee on Infectious Diseases. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017;139:e20163860.
   PubMed Web of Science ®Google Scholar
• Belk K, Connolly MP, Schlesinger L, et al. Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the vizient health systems data from 2011 to 2017. 2018; Pathog Glob Health. 2018;112:428–437.
   Google Scholar
• Lykins J, Wang K, Wheeler K, et al. Understanding toxoplasmosis in the United States through “Large data” analyses. Clin Infect Dis. 2016;63:468–475.
   PubMed Web of Science ®Google Scholar
• Jones JL, Holland GN. Annual Burden of ocular toxoplasmosis in the United States. Am J Trop Med Hyg. 2010;82:464–465.
   PubMed Web of Science ®Google Scholar
• Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the infectious Diseases Society of America. Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed 01/17/2019 [pages C-1 to to C-15].
   Google Scholar
• Jones JL, Hanson DL, Chu SY, et al. Toxoplasmic encephalitis in HIV-infected persons: risk factors and trends. The adult/Adolescent spectrum of disease group. AIDS. 1996;10:1393–1399.
   PubMed Web of Science ®Google Scholar
• Lopez A, Dietz VJ, Wilson M, et al. Preventing congenital toxoplasmosis. MMWR Recomm Rep. 2000;49(RR–2):59–68.
   PubMedGoogle Scholar
• Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England regional toxoplasma working group. N Engl J Med. 1994;330:1858–1863.
   PubMed Web of Science ®Google Scholar
• Buzby J, Roberts T. ERS updates U.S. Foodborne disease costs for seven pathogens, food review, the magazine of food economics, United States department of agriculture. Econ Res Serv. 1996;(Issue 3):1–6.
   Google Scholar
• Heslin KC, Elixhauser A. HIV hospital stays in the United States, 2006–2013. HCUP statistical brief #206. Rockville, MD: Agency for Healthcare Research and Quality; 2016 June.
   Google Scholar
• Pomares C, Devillard S, Holmes TH, et al. Genetic characterization of toxoplasma gondii DNA samples isolated from humans living in North America: an unexpected high prevalence of atypical genotypes. J Infect Dis. 2018;218:1783–1791.
   PubMed Web of Science ®Google Scholar
• Davis SM, Anderson BL, Schulkin J, et al. Survey of obstetrician-gynecologists in the United States about toxoplasmosis: 2012 update. Arch Gynecol Obstet. 2015;291:545–555.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. [Cited 2018 Sep 10] Avialable from: https://www.cdc.gov/dpdx/toxoplasmosis/index.html.
   Google Scholar
• Jones JL, Dietz VJ, Power M, et al. Survey of obstetrician-gynecologists in the United States about toxoplasmosis. Infect Dis Obstet Gynecol. 2001;9:23–31.
   PubMedGoogle Scholar
• Jones JL, Dargelas V, Roberts J, et al. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009;49:878–884.
   PubMed Web of Science ®Google Scholar
• Jones JL, Ogunmodede F, Scheftel J, et al. Toxoplasmosis-related knowledge and practices among pregnant women in the United States. Infect Dis Obstet Gynecol. 2003;11:139–145.
   PubMedGoogle Scholar
• Lum F, Jones JL, Holland GNet al. Survey of ophthalmologists about ocular toxoplasmosis. Am J Ophthalmol. 2005;140:724–726.
   PubMed Web of Science ®Google Scholar
• Flegr J, Prandota J, Sovičková M, et al. Toxoplasmosis–a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 2014;9:e90203.
   PubMed Web of Science ®Google Scholar
• Flegr J, Escudero DQ. Impaired health status and increased incidence of diseases in Toxoplasma-seropositive subjects - an explorative cross-sectional study. Parasitology. 2016;143:1974–1989.
   PubMed Web of Science ®Google Scholar
• Flegr J. Is there a relation between the manipulative activity of Toxoplasma and personalized medicine? Expert Rev Anti Infect Ther. 2018;16:1–3.
   PubMed Web of Science ®Google Scholar
• Hochberg NS, Bhadella N. Infections associated with exotic cuisine: the dangers of delicacies. Microbial Spectrum. 2015;3:IOL5–0010.
   Web of Science ®Google Scholar
• National Travel and Tourism Office. Monthly tourism statistics https://travel.trade.gov/research/monthly/departures/
   Google Scholar
• Cook AJ, Gilbert RE, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European research network on congenital toxoplasmosis. BMJ. 2000;321:142–147.
   PubMed Web of Science ®Google Scholar
• Anand R, Jones CW, Ricks JH, et al. Acute primary toxoplasmosis in travelers returning from endemic countries. J Travel Med. 2012;19:57–60.
   PubMed Web of Science ®Google Scholar
• Henao-Martínez AF, Franco-Paredes C, Palestine AG, et al. Symptomatic acute toxoplasmosis in returning travelers. Open Forum Infect Dis. 2018;5:ofy058.
   PubMed Web of Science ®Google Scholar
• Bottieau E, Clerinx J, Van Den Enden E, et al. Infectious mononucleosis-like syndromes in febrile travelers returning from the tropics. J Travel Med. 2006;13:191–197.
   PubMed Web of Science ®Google Scholar
• Abhilash KP, Roshine MK, Vandana K, et al. A probable case of acquired toxoplasmosis presenting as pyrexia of unknown origin in an immunocompetent individual. Int J Infect Dis. 2013;17:e1067–e1068.
   PubMed Web of Science ®Google Scholar
• Cummings PL, Kuo T, Javanbakht M, et al. Trends, productivity losses, and associated medical conditions among toxoplasmosis deaths in the United States, 2000–2010. Am J Trop Med Hyg. 2014;91:959–964.
   PubMed Web of Science ®Google Scholar
• Jones JL, Roberts JM. Toxoplasmosis hospitalizations in the United States, 2008, and trends, 1993–2008. Clin Infect Dis. 2012;54:e58–e61.
   PubMed Web of Science ®Google Scholar
• Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States–major pathogens. Emerg Infect Dis. 2011;17:7–15.
   PubMed Web of Science ®Google Scholar
• Collier SA, Stockman LJ, Hicks LA, et al. Direct healthcare costs of selected diseases primarily or partially transmitted by water. Epidemiol Infect. 2012;140:2003–2013.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: global Burden of disease study. Lancet. 1997;349:1436–1442.
   PubMed Web of Science ®Google Scholar
• Scallan E, Hoekstra RM, Mahon BE, et al. An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years. Epidemiol Infect. 2015;143:2795–2804.
   PubMed Web of Science ®Google Scholar
• Torgerson PR, Devleesschauwer B, Praet N, et al. World Health Organization estimates of the global and regional disease Burden of 11 foodborne parasitic diseases, 2010: a data synthesis. PLoS Med. 2015;12:e1001920.
   PubMed Web of Science ®Google Scholar
• Hoffmann S, Batz MB, Morris JG Jr. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot. 2012;75:1292–1302.
   PubMed Web of Science ®Google Scholar
• Scharff RL. Economic burden from health losses due to foodborne illness in the United States. J Food Prot. 2012;75:123–131.
   PubMed Web of Science ®Google Scholar
• Batz M, Hoffmann S, Morris JG Jr. Disease-outcome trees, EQ-5D scores, and estimated annual losses of quality-adjusted life years (QALYs) for 14 foodborne pathogens in the United States. Foodborne Pathog Dis. 2014;11:395–402.
   PubMed Web of Science ®Google Scholar
• Freedberg KA, Scharfstein JA, Seage GR 3rd, et al. The cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA. 1998;279:130–136.
   PubMed Web of Science ®Google Scholar
• Khetsuriani N, Holman RC, Anderson LJ. Burden of encephalitis-associated hospitalizations in the United States, 1988–1997. Clin Infect Dis. 2002;35:175–182.
   PubMed Web of Science ®Google Scholar
• Roberts T, Murrell KD, Marks S. Economic losses caused by foodborne parasitic diseases. Parasitol Today. 1994;10:419–423.
   PubMedGoogle Scholar
• Roberts T, Frenkel JK. Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. J Am Vet Med Assoc. 1990;196:249–256.
   PubMed Web of Science ®Google Scholar
• Flegr J. How and why toxoplasma makes us crazy. Trends Parasitol. 2013;9:156–163.
   Web of Science ®Google Scholar
• Centers for Disease Control [Cited 2018 Sep 10]. Avialable from: https://www.cdc.gov/parasites/toxoplasmosis/health_professionals/index.html.
   Google Scholar
• de-la-Torre A, Stanford M, Curi A, et al. Therapy for ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19:314–320.
   PubMed Web of Science ®Google Scholar
• Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965–1976.
   PubMed Web of Science ®Google Scholar
• Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008;47:554–566.
   PubMed Web of Science ®Google Scholar
• Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992;15(2):211–222.
   PubMed Web of Science ®Google Scholar
• Borkowski PK, Brydak-Godowska J, Basiak W, et al. The impact of short-term, intensive antifolate treatment (with Pyrimethamine and Sulfadoxine) and antibiotics followed by long-term, secondary antifolate prophylaxis on the rate of toxoplasmic retinochoroiditis recurrence. PLoS Negl Trop Dis. 2016;10:e0004892.
   PubMed Web of Science ®Google Scholar
• Connolly MP, Goodwin E, Schey C, et al. Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis. Pathog Glob Health. 2017a;111:31–44.
   PubMed Web of Science ®Google Scholar
• Martin-Blondel G, Alvarez M, Delobel P, et al. Toxoplasmic encephalitis IRIS in HIV-infected patients: a case series and review of the literature. J Neurol Neurosurg Psychiatry. 2011;82(6):691–693.
   PubMed Web of Science ®Google Scholar
• Connolly MP, Haitsma G, Hernández AV, et al. Systematic review and meta-analysis of secondary prophylaxis for prevention of HIV-related toxoplasmic encephalitis relapse using trimethoprim-sulfamethoxazole. Pathog Glob Health. 2017b;111:327–331.
   PubMed Web of Science ®Google Scholar